Skip to main content
. 2019 Jun 15;393(10189):2395–2403. doi: 10.1016/S0140-6736(19)30773-1

Table 3.

Secondary outcomes at 6 weeks post-delivery based on data from questionnaire (intention-to-treat population)

Amoxicillin and clavulanic acid (n=1296) Placebo (n=1297) Effect measure (99% CI) p value
Perineal pain 592 (46%) 707 (55%) 0·84 (0·76 to 0·93)* <0·0001
Missing 0 0 NA NA
Use of pain relief for perineal pain 99 (8%) 138 (11%) 0·72 (0·52 to 0·99)* 0·0073
Missing 13 18 NA NA
Need for additional perineal care 390 (31%) 543 (43%) 0·72 (0·63 to 0·83)* <0·0001
Missing 42 38 NA NA
Wound breakdown 142 (11%) 272 (21%) 0·52 (0·41 to 0·67)* <0·0001
Missing 4 7 NA NA
Dyspareunia 299 (55%) 280 (54%) 1·01 (0·87 to 1·17)* 0·873
Missing 5 8 NA NA
Breastfeeding at 6 weeks 662 (51%) 657 (51%) 1·01 (0·91 to 1·11)* 0·828
Missing 4 4 NA NA
Perineum ever too painful or uncomfortable to feed baby 136 (11%) 198 (17%) 0·69 (0·53 to 0·90)* <0·00025
Missing 96 98 NA NA
Hospital bed stay to discharge 1 (1–2) 1 (1–2) 0 (0 to 0) 0·318
Missing 0 0 NA NA
Any primary care or home visits in relation to perineum 361 (28%) 496 (38%) 0·73 (0·63 to 0·84)* <0·0001
Missing 3 5 NA NA
Any outpatient visits in relation to perineum 95 (7%) 173 (13%) 0·55 (0·40 to 0·75)* <0·0001
Missing 5 6 NA NA
Maternal hospital re-admission 63 (5%) 84 (7%) 0·75 (0·49 to 1·14)* 0·072
Missing 47 51 NA NA
Maternal health-related quality of life
EQ-5D-5L score 0·935 (0·098) 0·927 (0·111) 0·008 (−0·003 to 0·019)§ 0·048
Missing 16 18 NA NA

Data are n (%), n, median (IQR), or mean (SD). NA=not applicable. EQ-5D-5L=five-level EuroQol-5D questionnaire.

*

Risk ratio (risk in amoxicillin and clavulanic acid group/risk in placebo group).

Denominator is all women who have attempted intercourse since giving birth (n=544 amoxicillin and clavulanic acid group, n=514 control group).

Difference in medians for hospital bed stay to discharge.

§

Difference in means.